Sangeeta Yanglem

Ms. Sangeeta Yanglem

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2025 in Neuroglia
Verified
Journal Article
Open access
PDF file
BLBorish Loushambam
Borish Loushambam
SYSangeeta Yanglem
Sangeeta Yanglem
VKVenkateswaran Krishnaswami
Venkateswaran Krishnaswami
MKMUNISH of KUMAR
MUNISH of KUMAR
Sivakumar VijayaraghavaluSivakumar Vijayaraghavalu
Sivakumar Vijayaraghavalu
Background: Neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and spinal cord injury (SCI) are significant global health challenges due to their complex pathology and limited therapeutic options. Conventional treatments often fail to efficiently cross the blood–brain barrier (BBB), leading to poor bioavailability and systemic toxicity. This narrative review explores the potential of nanomedicine in addressing these limitations and advancing targeted therapies for neural disorders. Methods: This review examines recent studies on the use of engineered nanoparticles (NPs), including liposomes, dendrimers, micelles, and nanogels, for targeted drug delivery and multifunctional theranostics in neural diseases. It evaluates their role in promoting axon regeneration, reducing neuroinflammation, and repairing neural damage. Additionally, innovative applications in gene therapy and RNA-based treatments, such as CRISPR-Cas9 and RNA interference (RNAi), are discussed. Challenges related to toxicity, scalability, affordability, and regulatory barriers are highlighted, along with potential strategies to address these issues. Results: Nanoparticles have shown significant promise in crossing the BBB, delivering therapeutic agents to neural tissues, and minimizing off-target effects. Emerging applications in gene and RNA-based therapies demonstrate their versatility in addressing disease-specific challenges. However, unresolved issues such as long-term safety, manufacturing scalability, and cost continue to pose challenges. Conclusions: Nanomedicine offers a promising approach to overcoming current limitations in the treatment of neural disorders. This review emphasizes the need for continued interdisciplinary efforts to address translational barriers and highlights the potential for nanomedicine to improve the outcomes and quality of life for patients with neural disorders, stroke, and SCI.

16 March 2026 in Plant Science Today
Verified
Journal Article
Open access
PDF file
SYSangeeta Yanglem
Sangeeta Yanglem
SBS W Birjit
S W Birjit
KRK Reema
K Reema
WWW C Wairokpam
W C Wairokpam
TST Sonali
T Sonali
DMD D Maibam
D D Maibam
Homalomena aromatica (Spreng.) Schott is a highly aromatic medicinal plant found in Manipur and other parts of Northeast India. Despite its varied traditional medicinal uses, there are limited reports on plant-part-specific toxicological evaluation of the rhizome and leaf ethanol extracts. In vitro toxicological studies may not adequately replicate complex biological interactions such as metabolism and bioavailability. Therefore, this study focused on in vivo evaluation to obtain a comprehensive toxicological profile. This study compared the phytochemical composition of the rhizome and leaf ethanol extracts of H. aromatica from Manipur, India using gas chromatography-mass spectrometry (GC-MS), antioxidant activity using ABTS and DPPH assays and toxicological profile using zebrafish as a model. The GC-MS analysis of Homalomena aromatica rhizome ethanol extract (HAREE) and Homalomena aromatica leaf ethanol extract (HALEE) revealed the presence of 31 and 25 compounds respectively. The rhizome ethanol extract had a terpenoid-rich composition with the major compounds being Linalyl acetate (monoterpenoid), Oplopanonyl acetate (sesquiterpenoid) and (1R,7S,E)-7-Isopropyl4,10-dimethylenecyclodec-5-enol (sesquiterpenoid) while the leaf ethanol extract showed a more diverse chemical composition with 2-Cyclohexen-3-ol-1-one, 2-dodecanoyl- (vinylogous acid), α- Tocopherol-β-D-mannoside (vitamin E glycoside) and n-Hexadecanoic acid (long-chain fatty acid) being the major compounds detected. The rhizome extract showed a higher 2,2-azinobis-(3-ethylbenzothiazoline-6-sulphonate) (ABTS) and 2,2´-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity than the leaf extract with IC50 values of 51.23 ± 0.10 µg/mL (ABTS) and 248.81 ± 6.23 µg/mL (DPPH) respectively. However, both were less potent than the standard ascorbic acid. In contrast to the antioxidant activity, the leaf ethanol extract was found to have a higher toxic profile as compared to the rhizome ethanol extract with LC50 values estimated to be 198.81 (leaf) and 558.31 µg/mL (rhizome) respectively. This underscores differential distribution of secondary metabolites in the different plant parts. In conclusion, these findings highlight substantial differences between the leaf and rhizome extracts in chemical composition, antioxidant potential and safety profile.

15 June 2026 in Plant Science Today
Verified
Journal Article
Open access
PDF file
SBSingh Waikhom Birjit
Singh Waikhom Birjit
SYSangeeta Yanglem
Sangeeta Yanglem
YTYumnamcha Thangal
Yumnamcha Thangal
WWWangthoinganba Chenglei Wairokpam
Wangthoinganba Chenglei Wairokpam
TSThokchom Sonali
Thokchom Sonali
DMDamayanti Devi Maibam
Damayanti Devi Maibam
Ocimum basilicum L. (sweet basil) essential oil (EOOB) is widely used for its antimicrobial and therapeutic benefits; however, its safety and toxicity remain underexplored. This study provides the first integrated investigation of the chemical composition, antibacterial efficacy and developmental toxicity of EOOB using a zebrafish (Danio rerio) model. Ocimum basilicum essential oil (EOOB) was extracted by hydro-distillation and chemically characterised using gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectroscopy (FTIR) spectroscopy. The antibacterial activity of EOOB and its major constituent, methyl cinnamate (MeCin), was evaluated against Bacillus subtilis, Escherichia coli, Salmonella typhi and Staphylococcus aureus using agar well diffusion method and minimum inhibitory concentration (MIC) assays. Embryotoxicity and cardiotoxicity were assessed in zebrafish embryos at 24–96 hours post-fertilisation (hpf) to establish developmental safety profiles. The GC-MS analysis revealed MeCin (≈ 45.6 %) as the major constituent, followed by linalool, geraniol and eucalyptol. Ocimum basilicum essential oil (EOOB) exhibited stronger antibacterial activity than MeCin, suggesting possible synergistic interactions among minor terpenoids. Embryotoxicity assays demonstrated concentration-dependent developmental defects, including pericardial and yolk sac edema, spinal curvature and cardiac arrest, which were more pronounced in MeCin-treated embryos than in EOOB-treated embryos. The zebrafish model enabled direct visualisation of morphological and cardiac effects, providing a robust platform for toxicity assessment. This study is the first to correlate the phytochemical profile of a MeCin-rich O. basilicum chemotype with both antibacterial and embryotoxic outcomes in zebrafish. Overall, EOOB exhibited potent antibacterial activity with relatively lower developmental toxicity than its isolated major constituent, supporting the concept of whole-oil synergy. Furthermore, this study establishes zebrafish-based embryotoxicity screening as a novel, ethical and predictive approach for evaluating the safety of bioactive essential oils.

9 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SYSangeeta Yanglem
Sangeeta Yanglem
BLBorish Loushambam
Borish Loushambam
SSSorokhaibam Mexico Singh
Sorokhaibam Mexico Singh
SVSivakumar Vijayaraghavalu
Sivakumar Vijayaraghavalu
Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neu-rotoxic when the regulatory mechanism involved in their production, metabolism, com-partmentalization and clearance are disrupted. This shift underlies the basis of endoge-nous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neuro-toxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mi-tochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neu-ronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeosta-sis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework sug-gests that effective therapeutic strategies may require restoration of physiological regula-tory networks rather than targeting individual neurotoxic molecules in isolation. A sys-tems-level understanding of endogenous neurotoxicity may therefore facilitate the devel-opment of earlier biomarkers and more effective interventions aimed at preserving neu-ronal homeostasis and preventing progressive neurological dysfunction.

9 July 2026 in Plant Science Today
Verified
Journal Article
Open access
PDF file
SBS W Birjit
S W Birjit
SYSangeeta Yanglem
Sangeeta Yanglem
KRK Reema
K Reema
YTY Thangal
Y Thangal
SKS N Kistu
S N Kistu
DMD D Maibam
D D Maibam
Patchouli oil has diverse applications in food preservation, medicine and cosmetics. The present study investigated the phytochemical composition, antioxidant and antibacterial activities and embryotoxic potential of the essential oil of Microtoena patchoulii (C.B.Clarke ex Hook.f.) C.Y.Wu & S.J.Hsuan (EOMP). Phytochemical profiling was performed using gas chromatography-mass spectrometry (GC-MS) and Fourier transform infrared spectroscopy (FTIR). Antioxidant activity was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging assays. Antibacterial activity of EOMP and terpinolene was assessed by the agar well diffusion method against Escherichia coli, Bacillus subtilis, Salmonella typhi and Staphylococcus aureus. Minimum inhibitory concentrations (MICs) were determined using a 96-well microtiter plate assay with tetrazolium dye. Embryotoxicity was evaluated in zebrafish (Danio rerio). The GC-MS analysis identified terpinolene (10.15 %) as the major volatile constituent. The EOMP exhibited stronger ABTS radical scavenging activity (EC₅₀ = 6.995 µg/mL) than DPPH activity (EC₅₀ = 10.044 µg/mL). The antibacterial activity of EOMP was observed in the order: E. coli (24.6 ± 0.1 mm) > S. aureus (22.0 ± 0.1 mm) > S. typhi (20.4 ± 0.6 mm) > B. subtilis (18.6 ± 0.1 mm), with the lowest MIC recorded against E. coli (5.0 ± 0.0 µg/mL). Terpinolene showed comparatively lower antibacterial activity, with the lowest MIC observed against B. subtilis and S. aureus (2.0 ± 0.0 µg/mL). The median lethal concentration (LC₅₀) values of EOMP and terpinolene were 174.147 µg/mL and 201.409 µg/mL, respectively. Overall, EOMP demonstrated stronger antibacterial activity but higher embryotoxic potential than terpinolene.

30 October 2026 in Plant Science Today
Verified
Journal Article
Open access
PDF file
TST Sonali
T Sonali
SYSangeeta Yanglem
Sangeeta Yanglem
KRK Reema
K Reema
YTY Thangal
Y Thangal
WWWc Wairokpam
Wc Wairokpam
DMDd Maibam
Dd Maibam
Litsea cubeba (Lours.) Pers. is an aromatic plant whose fruits are extensively used in traditional medicine and as flavouring ingredients. Although widely used, the information regarding its phytochemical constituents and toxicity remains scarce. This study focused on identifying the phytochemicals present in the methanolic fruit extract of L. cubeba, as well as evaluating the embryotoxicity and developmental toxicity using zebrafish embryos as a model. Six hr post fertilisation (hpf) embryos were treated with 5, 10, 20, 30, 40 and 50 μg/mL of L. cubeba fruit extract (LCFE). Hatching rate was determined at 72 hpf while mortality rate and developmental abnormalities were determined at 96 hpf. Teratogenic index (TI) was calculated as the ratio of LC50/EC50. A teratogenic index value of ≥ 2 signifies teratogenic potential. To investigate the mechanism of toxicity, reactive oxygen species (ROS) production and cell death were evaluated by staining techniques. Phytochemical analysis by gas chromatography-mass spectrometry (GC-MS) identified 35 compounds, including linoleic acid, retinal, n-hexadecanoic acid, undec-10-ynoic acid, tridec-2-yn-1-yl ester, neral and seneciphylline N-oxide, which were previously reported for their toxic properties. Exposure of LCFE to zebrafish embryos caused embryotoxicity and developmental toxicity in a dose-dependent manner. The TI value of 2.3 suggested significant teratogenic potential of LCFE. Furthermore, LCFE-treated zebrafish embryos showed significant ROS production and elevated apoptosis, suggesting oxidative stress-mediated apoptosis might be the reason for the observed embryotoxicity and developmental malformations. However, further studies are required to elucidate the mechanisms that lead to the disruption of key developmental pathways and to identify the safe exposure levels of LCFE.